Immunogenomics approaches for vaccine evaluation.
Vaccines represent a potent tool to prevent or contain diseases with high morbidity or mortality. However, despite their widespread use, there is still a limited understanding of the mechanisms underlying the effective elicitation of protective immune responses by vaccines. The integrated co-operation between cells and molecules of innate and adaptive immune systems is under intense study by several groups and constantly updated. The recent development of new technologies and computational tools permits the comprehensive and quantitative analysis of the interactions between all of the components of immunity over time. This study reviews recent progress in exploiting an immunogenomics approach, within the systems biology strategy, to study and evaluate vaccine strategies for infectious and neoplastic diseases. The final goal of this approach is 2-fold, looking for novel and unpredictable mechanisms as well as identifying common immune signatures, relevant for predicting immune responsiveness to improve the design of vaccine strategies. Such approach, indeed, would enable the switch from 'empirical' to 'knowledge-based' vaccinology, leading to a patient-tailored treatment.
Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale Tumori 'Fond Pascale', Naples, Italy.
Annacarmen
A
Petrizzo
Marialina
M
Tornesello
Franco M
FM
Buonaguro
Luigi
L
Buonaguro
D056704:Adaptive Immunity; D000818:Animals; D003140:Communicable Disease Control; D003141:Communicable Diseases / Q000235:genetics / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007125:Immunogenetics / Q000379:methods*; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000517:prevention & control; D049490:Systems Biology / Q000379:methods; D014612:Vaccines / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use
D014612:Vaccines